Consultancy Services
Publié le
Clinical Research Consultants Our Clinical Research Consultants provide Clinical, Statistical and Regulatory Expert Services to accelerate the development of your drug, biomarker…
They Are Talking About IDDI
Publié le
IDDI in the Media BIOWIN Newsletter Deux projets de R&D dans les starting-blocks (July 2017): “TREATBEST, est un consortium composé…
Current Status of Surrogates for Survival in Cancer Trials
Publié le
IDDI organized a webinar on the Current Status of Surrogates for Survival in Cancer Trials. VIEW THE RECORDING OF THE…
Personalized Cancer Medicine Needs Randomized Trials
Publié le
IDDI organized a webinar on Personalized Cancer Medicine Needs Randomized Trials. Clinical cancer research is undergoing profound changes, mostly because…
From Biomarkers to In-vitro Companion Diagnostic Device
Publié le
IDDI organized a webinar on the analytical validation of in-vitro diagnostic devices entitled ‘From Biomarkers to In-vitro Companion Diagnostic Device :…
Future of Cancer Clinical Trials
Publié le
IDDI organized a webinar on the Future of Cancer Clinical Trials. Cancer clinical trials have been a major determinant of…
Implementing Adaptive Trials: Operational Considerations
Publié le
IDDI organized a webinar on Implementing Adaptive Trials: Operational Considerations. WATCH RECORDED WEBINAR TO ACCESS THE PRESENTATION OF THIS ON-DEMAND WEBINAR,…
Pros and Cons of Adaptive Designs
Publié le
IDDI organized a webinar on Pros and Cons of Adaptive Designs. Topics included: Continual reassessment methods for phase I trials Adaptive…
Efficient Designs in Phase I Trials in Oncology
Publié le
IDDI organized a webinar on Efficient Designs in Phase I oncology trials. The key learning objectives of this webinar were…
The Need for Better Endpoints: Towards a More Efficient Drug Development in Oncology
Publié le
IDDI organized a webinar on THE NEED FOR BETTER CLINICAL ENDPOINTS : TOWARDS A MORE EFFICIENT DRUG DEVELOPMENT IN ONCOLOGY The…